Azz Active powder for oral administration with blackberry aroma 600mg, No. 10

• Acute and chronic diseases of the respiratory system associated with the formation of viscous difficult-to-separate bronchial secretions (as an expectorant): bronchitis, tracheitis, bronchiolitis, pneumonia, bronchiectasis, cystic fibrosis, lung abscess, pulmonary emphysema, laryngotracheitis, interstitial lung diseases (due to atelectasis blockage of the bronchi with a mucous plug).

• Inflammation of the middle ear (otitis media), acute and chronic sinusitis, rhinosinusitis (relief of secretion discharge).

• Removal of viscous secretions from the respiratory tract in post-traumatic and postoperative conditions.

Inside.

The powder from 1 sachet should be poured directly onto the tongue. The drug stimulates salivation, so the powder mixes with saliva and is easily swallowed. The drug does not require drinking water. Oral powder should not be chewed before swallowing.

Adults: 1 sachet once a day (equivalent to 600 mg of acetylcysteine ??per day). Due to the high content of acetylcysteine ??(600 mg) in 1 sachet, the drug should not be used in children (it is recommended to use other dosage forms of ACCЃ or another acetylcysteine ??drug).

The duration of the course of treatment should be assessed individually. In case of short-term colds, the duration of the course is 5-7 days, in the treatment of chronic diseases - up to several months (as recommended by a doctor).

1 sachet contains:

active substance: acetylcysteine ??600 mg;

excipients: glyceryl tripalmitate, polysorbate 65, sorbitol, xylitol, citric acid, sodium dihydrogen citrate, magnesium citrate, sodium carmellose, aspartame, Blackberry 'B' flavoring (natural / identical to natural liquid flavoring 'Forest Berry', identical to 5752; natural / liquid flavoring 'Blackberry', code 5337; vanillin; maltodextrin; mannitol; gluconolactone; sorbitol; colloidal anhydrous silicon dioxide; magnesium carbonate), magnesium stearate.

• Hypersensitivity to acetylcysteine ??or other components of the drug; hemoptysis, pulmonary bleeding;

• peptic ulcer of the stomach and duodenum in the acute stage;

• children under 18 years of age (for this dosage form);

• pregnancy and the period of breastfeeding;

• hereditary fructose intolerance (contains sorbitol), phenylketonuria (contains a source of phenylalanine aspartame).

Pharmacological action
Mucolytic drug. Acetylcysteine ??is a derivative of the amino acid cysteine. It has a mucolytic effect, facilitates the discharge of sputum due to a direct effect on the rheological properties of sputum. The action is due to the ability to break disulfide bonds of mucopolysaccharide chains and cause depolymerization of mucoproteins in sputum, which leads to a decrease in the viscosity of sputum. The drug remains active in the presence of purulent sputum.
Side effects
Itching, rash, exanthema, urticaria, angioedema, decreased blood pressure, tachycardia, shortness of breath, bronchospasm (mainly in patients with bronchial hyperreactivity in bronchial asthma), stomatitis, abdominal pain, nausea, vomiting, diarrhea, heartburn, dyspepsia, noise in the ears, headache, fever, isolated reports of the development of bleeding due to the presence of a hypersensitivity reaction, a decrease in platelet aggregation.
Overdose
Symptoms: in case of an erroneous or deliberate overdose, such phenomena as diarrhea, vomiting, stomach pain, heartburn and nausea are observed.
Treatment: symptomatic.